News & Updates
Event Calendar
June 17, 2013 - 4:00pm
June 22, 2013 (All day)
Find A Specialist
Resource Finder at Kennedy Krieger Institute
Submitted by admin on June 23, 2011 - 3:08pm
A free resource that provides access to information and support for individuals and families living with developmental disabilities.
Biblio
Found 16 results
2010
Brodsky RA, Chen AR, Dorr D, Fuchs EJ, Huff CA, Luznik L, Smith DB, Matsui WH, Goodman SN, Ambinder RF et al..
2010. High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up.. Blood. 115(11):2136-41. Abstract
Luznik L, Bolaños-Meade J, Zahurak M, Chen AR, Smith DB, Brodsky R, Huff CA, Borrello I, Matsui W, Powell JD et al..
2010. High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.. Blood. 115(16):3224-30. Abstract
Kasamon YL, Luznik L, Leffell MS, Kowalski J, Tsai H-L, Bolaños-Meade J, Morris LE, Crilley PA, O'Donnell PV, Rossiter N et al..
2010. Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(4):482-9. Abstract
2008
Warlick ED, O'Donnell PV, Borowitz M, Grupka N, Decloe L, Garrett-Mayer E, Borrello I, Brodsky R, Fuchs E, Huff CA et al..
2008. Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes.. Leukemia research. 32(9):1439-47. Abstract
Luznik L, O'Donnell PV, Symons HJ, Chen AR, Leffell SM, Zahurak M, Gooley TA, Piantadosi S, Kaup M, Ambinder RF et al..
2008. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(6):641-50. Abstract
Matsui W, Wang Q, Barber JP, Brennan S, Smith DB, Borrello I, McNiece I, Lin L, Ambinder RF, Peacock C et al..
2008. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance.. Cancer research. 68(1):190-7. Abstract
2007
Bolaños-Meade J, Garrett-Mayer E, Luznik L, Anders V, Webb J, Fuchs EJ, Huff CA, Matsui W, Borrello IM, Brodsky R et al..
2007. Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 13(10):1185-91. Abstract
2006
Huff CA, Fuchs EJ, Smith DB, Blackford A, Garrett-Mayer E, Brodsky RA, Flinn IW, Ambinder RF, Borrello IM, Matsui WH et al..
2006. Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 12(4):414-21. Abstract
2005
Angstreich GR, Matsui W, Huff CA, Vala MS, Barber J, Hawkins AL, Griffin CA, Smith DB, Jones RJ.
2005. Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors.. British journal of haematology. 130(3):373-81. Abstract
2003
Huff CA, Fuchs EJ, Noga SJ, O'Donnell PV, Ambinder RF, Diehl L, Borrello I, Vogelsang GB, Miller CB, Flinn IA et al..
2003. Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cells.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 9(5):312-9. Abstract
2002
Huff CA, Jones RJ.
2002. Bone marrow transplantation for multiple myeloma: where we are today.. Current opinion in oncology. 14(2):147-51. Abstract

